Delivery Order SPE2DB22D3016-SPE2DB25FALY2

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,687.18, is for the delivery of 4567126452 KETOROLAC 30 MG/ML VIALML. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,939.60, is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,791.70 delivery order is for KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, and has a completion date of May 12, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,209.90 Firm Fixed Price Delivery Order is for the supply of ketorolac 30 mg/ml vials, a pain management medication. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,551.68 firm fixed-price delivery order is for the supply of 4566477690 KETOROLAC 30 MG/ML VIALML, a medication used for pain management. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,879.12, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This award is for the supply of 4567060543 - Ketorolac 30 mg/ml vials, a pain management medication. The contract has no set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $36,609.78 for the supply of KETOROLAC 60MG/2ML 25S, a pain medication. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense that provides medical supplies and equipment to military treatment facilities and other government healthcare programs. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $1,163.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/ml vials, a medication used for pain management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $5,035.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ketorolac 30 mg/ml vial, a pain medication, to support military treatment facilities and other federal healthcare providers. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,499.61 Firm Fixed Price delivery order is for the supply of Ketorolac 60 mg/2 ml vials, a pain medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FALY2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,217.47 firm fixed-price delivery order is for the supply of KETOROLAC 30 MG/ML VIALML, a pain medication.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there are no major subcontractors mentioned. The contract will be performed in Conshohocken, PA and has a performance period through February 3, 2025.

Generated 5/2/25, 9:57 AM